e.l.f. Beauty ELF
99.51
(1.06)
(1.05%)
as of 25 Sep
- Market cap
- $5.9B
- P/E
- 99.5×
Follow ELF
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
91.37 | 42.24 | 131.76 | 74.00 |
P/S ratio |
5.58 | 2.97 | 2.16 | 2.48 | |
P/FCF ratio |
54.46 | 21.02 | 18.58 | 15.62 | |
P/Operating CF |
330.21 | 75.90 | 34.47 | 39.19 | |
P/B ratio |
6.79 | 3.88 | 3.12 | 3.74 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
6.06 | 3.39 | 2.51 | 2.78 | |
EV/EBITDA |
43.51 | 21.89 | 26.60 | 22.10 | |
EV/Operating CF |
48.78 | 20.96 | 19.33 | 16.48 | |
EV/FCF |
59.10 | 24.05 | 21.61 | 17.46 | |
Quick Ratio |
1.33 | 1.52 | 1.38 | 1.54 | |
Current Ratio |
2.70 | 2.76 | 2.35 | 2.55 | |
Net Debt/EBITDA |
25.03 | 7.26 | (24.47) | 4.00 | |
Debt/Assets |
36.83% | 36.44% | 36.15% | 34.96% | |
Debt/Equity |
0.75 | 0.73 | 0.77 | 0.74 | |
Asset Turnover |
0.78 | 0.85 | 0.90 | 0.93 | |
Operating CF/Net income |
7.82 | 1.51 | (2.08) | 1.68 | |
Capex/Depreciation |
(0.37) | (0.30) | (0.07) | (0.05) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
67.20% | 57.19% | 71.03% | 58.48% | |
Intangible Assets out of Total Assets |
0.62 | 0.61 | 0.59 | 0.57 | |
Share Based Compensation of Revenue |
8.57% | 6.10% | 3.94% | 4.10% | |
Graham Net Nets |
(0.06) | (0.10) | (0.13) | (0.10) | |
Graham Number |
25.23 | 28.17 | 14.17 | 21.09 | |
Earnings Yield |
1.09% | 2.37% | 0.76% | 1.35% | |
Free Cash Flow Yield |
1.84% | 4.76% | 5.38% | 6.40% | |
Revenue per Share |
5.89 | 8.26 | 7.71 | 8.11 | |
Operating CF per Share |
0.40 | 1.00 | 1.76 | 1.89 | |
Capex per Share |
(0.12) | (0.11) | (0.03) | (0.02) | |
Free Cash Flow per Share |
0.28 | 0.89 | 1.73 | 1.86 | |
Cash per Share |
3.33 | 3.32 | 4.97 | 5.82 | |
Shareholders Equity per Share |
19.52 | 19.59 | 19.40 | 19.76 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
19.52 | 19.59 | 19.40 | 19.76 | |
Free Cash Flow |
16.57 | 52.79 | 100.57 | 110.23 | |
Working Capital |
445.37 | 447.29 | 453.20 | 522.19 | |
Capital Expenditures |
(6.85) | (6.62) | (1.88) | (1.43) | |
Net Current Asset Value |
(472.54) | (460.28) | (474.26) | (431.92) | |
EV/EBIT |
61.78 | 30.66 | 55.78 | 38.42 | |
Capex to Sales |
0.02 | 0.01 | 0.00 | 0.00 | |
Net Profit Margin |
0.87% | 8.04% | (10.99%) | 13.89% | |
Price to Operating Income |
56.92 | 26.79 | 47.96 | 34.36 | |
| Other line items | |||||
Average Receivables |
150.62 | 189.02 | 150.33 | 173.94 | |
Average Payables |
101.46 | 69.64 | 84.82 | 85.26 | |
Average Inventory |
243.09 | 217.70 | 203.71 | 208.60 | |
Average Assets |
1,777.90 | 1,794.28 | 1,821.17 | 1,887.77 | |
Average Common Equity |
933.35 | 964.62 | 945.69 | 986.87 |
Columns are period end dates